FreedomFlow Orbital Atherectomy Platform
Occlusive atherosclerotic peripheral artery disease (PAD)
Key Facts
About Cardio Flow
Cardio Flow is a commercial-stage medical device company focused on improving treatment for peripheral artery disease (PAD) through its innovative FreedomFlow Orbital Atherectomy Platform. The platform features a unique helical driveshaft with diamond-coated spheres, leveraging angular momentum to debulk plaque in vessels from 2mm to 8mm in diameter. With two clinical trials (FAST I and FAST II) completed and real-world evidence gathered, the company is positioned in the competitive atherectomy market, emphasizing procedural efficiency, a low learning curve, and reduced capital costs for healthcare providers. Its commercial strategy targets hospitals, ambulatory surgery centers, and office-based labs.
View full company profile